Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Current studies on continuous glucose monitor (CGM) uptake are revealing for significant barriers and inequities for CGM use among patients from socially underprivileged communities. This study explores the effect of full subsidies regardless of diabetes type on CGM uptake and HbA1c outcomes in a U.S. adult patient population on Medicaid. RESEARCH DESIGN AND METHODS: This retrospective cohort study examined 3,036 adults with diabetes enrolled in a U.S. Medicaid program that fully subsidized CGM. CGM uptake and adherence were assessed by CGM prescription and dispense data, including more than one fill and adherence by medication possession ratio (MPR). Multivariate logistic regression evaluated predictors of CGM uptake. Pre- and post-CGM use HbA1c were compared. RESULTS: CGM were very well received by both individuals with type 1 diabetes and individuals with type 2 diabetes with similar high fill adherence levels (mean MPR 0.78 vs. 0.72; P = 0.06). No significant difference in CGM uptake outcomes were noted among major racial/ethnic groups. CGM use was associated with improved HbA1c among those with type 2 diabetes (−1.2% [13.1 mmol/mol]; P < 0.001) that was comparable between major racial/ethnic groups and those with higher fill adherence achieved greater HbA1c reduction (−1.4% [15.3 mmol/mol]; P < 0.001) compared with those with lower adherence (−1.0% [10.9 mmol/mol]; P < 0.001). CONCLUSIONS: CGM uptake disparities can largely be overcome by eliminating CGM cost barriers. CGM use was associated with improved HbA1c across all major racial/ethnic groups, highlighting broad CGM appeal, utilization, and effectiveness across an underprivileged patient population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Addala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., Walker, A., Rosenbauer, J., Maahs, D. M., & Holl, R. W. (2021) · Diabetes Care · doi:10.2337/dc20-0257 · Cited by 283
Racial–Ethnic Disparities in Diabetes Technology use Among Young Adults with Type 1 Diabetes
Agarwal, S., Schechter, C., Gonzalez, J., & Long, J. A. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0338 · Cited by 182
Barriers to Technology Use and Endocrinology Care for Underserved Communities With Type 1 Diabetes
Walker, A. F., Hood, K. K., Gurka, M. J., Filipp, S. L., Anez-Zabala, C., Cuttriss, N., Haller, M. J., Roque, X., Naranjo, D., Aulisio, G., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2753 · Cited by 121
Lai, C. W., Lipman, T. H., Willi, S. M., & Hawkes, C. P. (2021) · Diabetes Care · doi:10.2337/dc20-1663 · Cited by 114
Johnson, S. R., Holmes-Walker, D. J., Chee, M., Earnest, A., & Jones, T. W. (2022) · Diabetes Care · doi:10.2337/dc21-1666 · Cited by 86 · cited 1×
“Of note, CGM fill adherence was a significant predictor of greater HbA1c improvement among those with type 2 diabetes, which builds on previous studies among those with type 1 diabetes that noted enhanced HbA1c improvement with more frequent CGM use and highlights the potential of CGM use to catalyze better diabetes m…”
Result
Cited by
Ebekozien, O., Fantasia, K., Farrokhi, F., Sabharwal, A., & Kerr, D. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15470 · Cited by 70
“37 Recommendation : Improving awareness of and use of federal programmes to improve the affordability of internet services 38 as well as supporting additional governmental funding to improve the availability of services, 39 particularly in rural areas, will be critical to enable access to digital…”
BackgroundReed, J., Dong, T., Eaton, E., Friswold, J., Porges, J., Al‐Kindi, S. G., Rajagopalan, S., & Neeland, I. J. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15608 · Cited by 22
Albanese-O’Neill, A. (2023) · Diabetes Spectrum · doi:10.2337/dsi23-0006 · Cited by 9
Metadata
- Authors
- Ni, K., Tampe, C. A., Sol, K., Richardson, D. B., & Pereira, R. I.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2022-12-08
- Volume
- 46
- Issue
- 2
- Pages
- 391-398
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4310965135
- Cited by
- 47
- References
- 7
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes. https://app.cochat.ai/papers/10.2337/dc22-1287
- The paper
- Ni, K., Tampe, C. A., Sol, K., Richardson, D. B., & Pereira, R. I. (2023). Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes. Diabetes Care. https://doi.org/10.2337/dc22-1287
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.